Tesofensine Caps (500mcg)
Tesofensine is a synthetic small-molecule research compound studied for its effects on monoamine reuptake and appetite-related signaling pathways. This capsule format delivers Tesofensine in a stabilized oral dosage form for laboratory research use.
Tesofensine is examined in laboratory settings for its triple monoamine reuptake inhibition (dopamine, noradrenaline, and serotonin), which influences hypothalamic appetite-regulation circuits.
GENIQ supplies Tesofensine Caps strictly for laboratory research only—not for human or animal use.
$199.99
-
Official retailer
-
Quality guaranteed
-
Free delivery from $99
-
Free returns is available
What Is Tesofensine Caps?
Tesofensine is a synthetic small-molecule research compound studied for its effects on monoamine reuptake and appetite-related signaling pathways. This capsule format delivers Tesofensine in a stabilized oral dosage form for laboratory research use. Tesofensine is examined in laboratory settings for its triple monoamine reuptake inhibition (dopamine, noradrenaline, and serotonin), which influences hypothalamic appetite-regulation circuits. GENIQ supplies Tesofensine Caps strictly for laboratory research only—not for human or animal use.
Peptide Overview
Tesofensine is frequently studied in research focused on appetite regulation, energy expenditure, and central nervous system monoamine signaling. In controlled laboratory environments, researchers examine how Tesofensine Caps may promote changes in:
| Dopamine reuptake inhibition pathways |
| Noradrenaline and serotonin signaling |
| Hypothalamic appetite-regulation circuits |
| Energy expenditure-related gene expression |
| Food-intake behavioral research models |
| Body-weight regulation signaling |
| Central nervous system monoamine research |
All findings remain limited to preclinical and in-vitro experimental environments.
History of Tesofensine
Tesofensine was originally developed by NeuroSearch as an investigational compound for neurodegenerative disease research before its appetite-suppressing properties were identified in clinical trials. Scientists observed that its triple monoamine reuptake inhibition produced pronounced reductions in food intake in study participants. Because of this interaction, Tesofensine became a compound of interest in studies involving:
| Appetite and satiety signaling research |
| Obesity and metabolic syndrome models |
| Monoamine reuptake pharmacology |
| Energy homeostasis mechanisms |
| Central nervous system stimulant research |
| Body-composition research protocols |
Peptide Structure
Chemical Name: Tesofensine (NS2330) Classification: Triple monoamine reuptake inhibitor (small molecule) Form Supplied: Oral capsule, 500mcg per capsule (100 capsules per bottle)
Certificates of Analysis
Every batch of GENIQ Tesofensine Caps is verified by third-party laboratory testing confirming identity, purity, and capsule content accuracy. Certificates of Analysis (COA) are available upon request for research verification.
Research Findings
Research involving Tesofensine commonly focuses on:
| Monoamine reuptake inhibition: Studies evaluate dopamine, noradrenaline, and serotonin transporter activity. |
| Appetite-suppression signaling: Researchers investigate hypothalamic pathways linked to reduced food intake. |
| Energy expenditure markers: Laboratory models track metabolic rate changes during administration. |
| Body-weight research models: Experimental studies analyze weight-related outcomes in controlled settings. |
| CNS pharmacology: Investigations explore central nervous system signaling tied to monoamine transporters. |
These findings reflect laboratory experiments only and do not indicate clinical outcomes.
References
FAQ
What type of research is Tesofensine Caps used for?
Tesofensine Caps is commonly used in studies involving appetite regulation, monoamine reuptake, and energy-metabolism research.
Does GENIQ provide a Certificate of Analysis?
Yes. Every GENIQ compound includes a COA verifying identity and purity.
Is Tesofensine approved for human or veterinary use?
No. Tesofensine is not FDA-approved and is intended strictly for laboratory research, not for human or animal administration.
Does GENIQ provide dosing or preparation instructions?
No. GENIQ does not provide dosing, administration, or preparation instructions, as our compounds are supplied strictly for laboratory research.
Who should handle this compound?
Tesofensine Caps should only be handled by qualified researchers and laboratory professionals trained in proper handling procedures.
Research Use Only
All GENIQ compounds are intended strictly for laboratory research.
Not for human or animal consumption, medical use, or therapeutic application.
Nothing in this document should be interpreted as medical advice or as approval for use outside controlled scientific environments.
Tesofensine is a synthetic small-molecule research compound studied for its effects on monoamine reuptake and appetite-related signaling pathways. This capsule format delivers Tesofensine in a stabilized oral dosage form for laboratory research use.
Tesofensine is examined in laboratory settings for its triple monoamine reuptake inhibition (dopamine, noradrenaline, and serotonin), which influences hypothalamic appetite-regulation circuits.
GENIQ supplies Tesofensine Caps strictly for laboratory research only—not for human or animal use.
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.